| 2019 novel coronavirus (COVID-19) outbreak: a review of the current literature AR Sahin, A Erdogan, PM Agaoglu, Y Dineri, AY Cakirci, ME Senel, ... EJMO 4 (1), 1-7, 2020 | 785 | 2020 |
| A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention S Ahmad Authorea Preprints, 2022 | 431 | 2022 |
| Corona virus: a review of COVID-19 D Kumar, R Malviya, PK Sharma EJMO 4 (1), 8-25, 2020 | 417 | 2020 |
| Modeling and Forecasting for the number of cases of the COVID-19 pandemic with the Curve Estimation Models, the Box-Jenkins and Exponential Smoothing Methods H Yonar, A Yonar, MA Tekindal, M Tekindal EJMO 4 (2), 160-165, 2020 | 140 | 2020 |
| The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2 RR Narkhede, RS Cheke, JP Ambhore, SD Shinde Eurasian Journal of Medicine and Oncology 4 (3), 185-195, 2020 | 138 | 2020 |
| A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients. ATMM Chowdhury, M Shahbaz, MR Karim, J Islam, D Guo, S He | 108 | 2020 |
| Another epidemic in the shadow of Covid 19 pandemic: a review of monkeypox RA Okyay, E Bayrak, E Kaya, AR Şahin, BF Koçyiğit, AM Taşdoğan, ... proteins 7 (10), 10.14744, 2022 | 78 | 2022 |
| In silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors H Hashem | 75 | 2020 |
| Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions M Rahmati, MA Moosavi mortality 4 (2), 179-180, 2020 | 70 | 2020 |
| Frequency of RAS mutations (KRAS, NRAS, HRAS) in human solid cancer H Kodaz, O Kostek, MB Hacioglu, B Erdogan, CE Kodaz, I Hacibekiroglu, ... Breast cancer 7 (12), 1-7, 2017 | 67 | 2017 |
| Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries F Öztoprak, A Javed ejmo 21, 24, 2020 | 39 | 2020 |
| Hydroxychloroquine as potent inhibitor of COVID-19 main protease: Grid based docking approach JK Malik, H Soni, S Sharma, S Sarankar Eurasian Journal of Medicine and Oncology 4 (3), 219-226, 2020 | 30 | 2020 |
| Genome organization of Covid-19 and emerging severe acute respiratory syndrome Covid-19 outbreak: a pandemic HS Dagur, SS Dhakar EJMO 4 (2), 107-115, 2020 | 30 | 2020 |
| Psychiatric disorders and symptoms in children and adolescents during the COVID-19 pandemic: A review MK Gul, E Demirci Eurasian Journal of Medicine and Oncology 5 (1), 20, 2021 | 29 | 2021 |
| The rise of new coronavirus infection (COVID-19): A recent update and potential therapeutic candidates SN Mali, AP Pratap, BR Thorat EJMO 4 (1), 35-41, 2020 | 27 | 2020 |
| Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection? MT Ramazan Azim Okyay, Ahmet Rıza Sahin, Rene A. Aguinada Eurasian Journal of Medicine and Oncology 4 (1), 104-105, 2020 | 19* | 2020 |
| The impacts of covariates on spatial distribution of corona virus 2019 (COVID-19): what do the data show through ANCOVA and MANCOVA HT Likassa EJMO 4 (2), 141-148, 2020 | 18 | 2020 |
| Artificial intelligence and machine learning in oncology: historical overview of documents indexed in the web of science database IH Musa, TH Musa, I Zamit, M Okeke Eurasian J Med Oncol 5 (3), 239-248, 2021 | 16 | 2021 |
| Silver Nanoparticles–A Review A Panja, AK Mishra, M Dash, NK Pandey, SK Singh, B Kumar Eurasian Journal of Medicine and Oncology 5 (2), 95, 2021 | 14 | 2021 |
| Investigation of the efficacy of algan hemostatic agent in liver laceration model in rats A Midi, A Kumandas, H Ekici, F Bayraktar, K Karapirli, S Karahan, M Turk, ... EJMO 3 (1), 37-42, 2019 | 14 | 2019 |
